Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report
We report the case of a 25-year-old pregnant woman who was diagnosed with aquaporin-4 antibody-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) at 19 weeks of gestation. During the acute stage of the disease, she was treated with high-do…